ANIP 52.11 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 10:19 AM

ANIP 52.11 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 53.20 Closing the day 09:45 at 52.11 -0.59 -1.12% With a day low of 51.91 and a total volume of 25,067.

ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 44 mins ago
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 52.36 (-0.34), ICPT: 161.65 (-1.31), AMAG: 34.71 (-0.22), AFFX: 9.79 (+0.01)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 51 mins ago
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 52.36 (-0.34)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 52.36 (-0.34), SCMP: 11.50 (+1.08)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 52.36 (-0.34)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 321.32 (+0.30), ANIP: 52.36 (-0.34), CLDX: 15.12 (+0.31), AMAG: 34.71 (-0.22)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.01 (-0.08), ANIP: 52.36 (-0.34), ACGL: 57.61 (+0.19), ACCO: 8.92 (+0.06), FLWS: 9.18 (+0.15)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 52.36 (-0.34)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 24.15 (-0.17), HBNK: 20.20 (unch), ASMI: 41.41 (+0.41), RRGB: 69.78 (+0.02), SAPE: 24.73 (+0.10), PLUG: 4.27 (+0.03), ANIP: 52.36 (-0.34), ODP: 6.83 (-0.01), MTEX: 23.15 (+0.37), JAXB: 11.75 (-0.15), ALQA: 5.20 (+0.10), YRCW: 24.68 (-0.02)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.45 (-0.14), NEO: 4.90 (-0.04), AU: 8.82 (-0.18), FNHC: 26.15 (+0.37), AMS: 2.81 (+0.30), NYMX: 0.53 (-0.05), AMDA: 1.27 (+0.02), CVD: 100.74 (+0.01), GBIM: 6.48 (+0.03), RCAP: 9.79 (-1.80), KBIO: 2.09 (-0.02), COOL: 0.96 (+0.04), SAPE: 24.73 (+0.10), XTLB: 2.40 (-0.18), GERN: 2.39 (+0.02), ANIP: 52.36 (-0.34), BBLU: 1.38 (+0.07), NXTD: 2.47 (+0.01), AP: 18.95 (+0.26), ALQA: 5.20 (+0.10)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 52.36 (-0.34)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 52.36 (-0.34)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 52.36 (-0.34)

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 52.36 (-0.34)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.94 (+0.07), SYY: 38.98 (+0.04), L: 43.11 (-0.14), EEP: 36.86 (+0.27), SNH: 22.33 (+0.01), INN: 11.57 (-0.04), ITG: 19.62 (+0.03), NSP: 33.60 (-0.22), S: 5.04 (+0.04), ALE: 50.84 (-0.41), GVA: 37.51 (-0.08), MCY: 55.28 (+0.14), ARNA: 4.83 (+0.13), CHD: 74.56 (+0.22), ARE: 83.09 (+0.34), USAK: 18.45 (-0.03), BWP: 16.96 (-0.10), KRG: 26.87 (+0.07), CYOU: 22.52 (-0.28), MNKD: 6.26 (+0.18), HNT: 49.92 (+0.47), AMH: 17.28 (+0.07), ARCB: 43.11 (-0.27), ANIP: 52.36 (-0.34), AMG: 198.98 (-1.25), HAE: 37.15 (+0.10), SOHU: 51.30 (+0.04), CNA: 39.23 (-0.30)

ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 106.23 (-0.10), MACK: 8.45 (-0.10), ANIP: 52.36 (-0.34), ILMN: 190.94 (+4.02)

ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT

ANIP: 52.36 (-0.34)

5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 52.36 (-0.34), KTOS: 5.37 (+0.03), BLOX: 16.93 (+0.11), CSLT: 12.05 (-0.10), FPRX: 14.32 (-0.22)

ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results
PR Newswire - Mon Oct 27, 7:30AM CDT
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results on Monday, November 3, 2014, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com.
ANIP: 52.36 (-0.34)

3 Money-Making Biotech Stocks That Could Go Higher
Todd Campbell, The Motley Fool - Motley Fool - Fri Oct 24, 7:34AM CDT
Biotechnology investors often have to make bets based more on promise than profit. That's because it takes years and hundreds of millions of dollars to advance new medicine through clinical trials to market, so investing in biotech stocks is more of...
INSY: 38.90 (-0.75), ANIP: 52.36 (-0.34), AMGN: 161.47 (-0.46), NPSP: 29.50 (+0.33), TEVA: 58.21 (-0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Consumer365 Highlights Happy Head's Personalized Hair Solutions

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

GEEKOM A5 2027: Mini PC Built to Boost Your Game

GEEKOM Raises the Bar with A5 2027 Build Every once in a blue moon, a piece of tech pricks up my ears and this time it's the GEEKOM A5 2027 Edition. Released on September 7, 2026, this contraption's not just joining the ranks—it's looking to redefine them. It's geared for the real-world junkie who’s raking through browser tabs, dropping into video meetings, and making...

CME Group Smashes FX Open Interest Record Again

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Regeneron Faces Class Action Over Tumultuous Trial Results

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Jixingfeng Advances Smart Manufacturing for Socks Market

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Europe's Largest Carbon Capture Facility Launches

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Lida Group Expands Global Modular Construction Services

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Innventure Faces Class Action: SEC Whistleblowers Invited

When Fiction Meets the Stock Market Here's a wild twist in the investment world: Innventure, Inc. (NASDAQ: INV) found itself in hot water, as its stock took a nosedive, plunging 55% on August 14, 2026. Imagine seeing your investments crumble just like that. What lit this fire? The decision to yank their DarkNX project from 2026 expectations and hit pause on their revenue...

York Space Systems Faces Investor Lawsuit Over Claims

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...